Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation

被引:0
|
作者
A Galy
S Rudraraju
R Baynes
J Klein
机构
[1] Stem Cell Transplantation Program,
[2] Barbara Ann Karmanos Cancer Institute,undefined
[3] Wayne State University,undefined
来源
关键词
dendritic cells; naive T cells; CD34; cell transplant; flow cytometry;
D O I
暂无
中图分类号
学科分类号
摘要
Following high-dose chemotherapy (HDC) and peripheral blood progenitor cell transplantation (PBPCT), there are profound changes in leukocyte homeostasis and the immune system is compromised. Transplantation of purified CD34+ cells may further compromise immune recovery because the grafts are depleted of mature immune cells. However, a detailed monitoring of immune cell reconstitution has not been done. We monitored blood levels of antigen-presenting cells (APC) and of lymphocytes by multi-color flow cytometry at different times post CD34+ PBPCT. We found a rapid normalization of circulating levels of the antigen-presenting CD11c+ dendritic cells (defined as lineage− HLA-DR+ CD11c+ cells). There was a slight over-representation of lin− DR+ CD11c− cells at day 42 post transplantation suggesting that the composition of the APC population might be affected. Normal levels of total T, B and NK lymphocytes were rapidly achieved but the composition of the T cell population was abnormal. Patients had elevated levels of CD8+ T cells at early times and a persistent reduction in levels of naive CD8+ T cells (CD8+ CD4− CD45RA+ CD27+) and of naive CD4+ T cells (CD4+CD3+ CD8− CD45RA+). Thus, we found a rapid recovery of DC after CD34+ PBPCT but the specific numerical defects in naive T cells are likely to be a major cause of immune dysfunction in the patients. Bone Marrow Transplantation (2000) 25, 1249–1255.
引用
收藏
页码:1249 / 1255
页数:6
相关论文
共 50 条
  • [21] CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer
    Baron, F
    Copizza, S
    Baudoux, E
    Jerusalem, G
    Fillet, G
    Beguin, Y
    HAEMATOLOGICA, 2004, 89 (09) : 1146 - 1148
  • [22] DNA Methylation and Hydroxymethylation Profile of CD34+-Enriched Cell Products Intended for Autologous CD34+ Cell Transplantation
    Rozman, Jasmina-Ziva
    Perme, Maja Pohar
    Jez, Mojca
    Malicev, Elvira
    Krasna, Metka
    Vrtovec, Bojan
    Rozman, Primoz
    DNA AND CELL BIOLOGY, 2017, 36 (09) : 737 - 746
  • [23] Molecular remission in adult T cell leukemia after autologous CD34+ peripheral blood stem cell transplantation
    Nakane, M
    Ohashi, K
    Sato, Y
    Moriya, A
    Inoue, T
    Mori, S
    Tanikawa, S
    Akiyama, H
    Maeda, Y
    Sasaki, T
    Karasawa, K
    Okuyama, Y
    Hiruma, K
    Sakamaki, H
    BONE MARROW TRANSPLANTATION, 1999, 24 (02) : 219 - 221
  • [24] Diminished T-cell recovery after CD34+ selected autologous peripheral blood stem cell transplantation increases the risk of cytomegalovirus infection
    Nishio, M
    Koizumi, K
    Endo, T
    Fujimoto, K
    Koike, T
    Sawada, K
    HAEMATOLOGICA, 2001, 86 (06) : 667 - 668
  • [25] CD34+ cell dose and CD33- subsets:: collection and engraftment kinetics in autologous peripheral blood stem cells transplantation
    Mayol, AS
    Vital, JB
    Llodrá, AG
    Lleonart, JB
    Flori, NM
    Sureda, MM
    García, AN
    Riera, MM
    Bach, EG
    García, PM
    HAEMATOLOGICA, 1998, 83 (06) : 489 - 495
  • [26] The impact of the number of CD34+ cells infused on the hematologic recovery after autologous peripheral blood stem cell (PBSC) transplantation.
    Palomera, L
    Azaceta, G
    Varo, MJ
    Moreno, JA
    Olave, T
    Domingo, JM
    Mayordomo, JI
    Gutiérrez, M
    BLOOD, 1998, 92 (10) : 304B - 304B
  • [27] Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation
    G Koehne
    W Zeller
    M Stockschlaeder
    AR Zander
    Bone Marrow Transplantation, 1997, 19 : 149 - 156
  • [28] Phenotype of lymphocyte subsets after autologous peripheral blood stem cell transplantation
    Koehne, G
    Zeller, W
    Stockschlaeder, M
    Zander, AR
    BONE MARROW TRANSPLANTATION, 1997, 19 (02) : 149 - 156
  • [29] Importance of CD34+ cell subsets in autologous PBSC transplantation:: the Mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment
    Hénon, P
    Sovalat, H
    Bourderont, D
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 62 - 67
  • [30] Human dendritic cell subsets in NOD/SCID mice engrafted with CD34+ hematopoietic progenitors
    Palucka, AK
    Gatlin, J
    Blanck, JP
    Melkus, MW
    Clayton, S
    Ueno, H
    Kraus, ET
    Cravens, P
    Bennett, L
    Padgett-Thomas, A
    Marches, F
    Islas-Ohlmayer, M
    Garcia, JV
    Banchereau, J
    BLOOD, 2003, 102 (09) : 3302 - 3310